ici 118551 has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, XJ; Hu, HY; Kiriazis, H; Lu, Q; Nguyen, MN; Puthalakath, H; Sadoshima, J; Su, Y; Wang, LN; Zhao, WB; Ziemann, M | 1 |
| Abe, H; Anson, BD; Delisle, BP; January, CT; Kawakami, K; Kikuchi, K; Nagatomo, T; Nakashima, Y; Takemasa, H | 1 |
2 other study(ies) available for ici 118551 and Cardiovascular Diseases
| Article | Year |
|---|---|
Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bcl-2-Like Protein 11; Cardiovascular Diseases; Carvedilol; Cell Line; Dose-Response Relationship, Drug; Galectin 3; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta-3; Signal Transduction; Up-Regulation | 2019 |
Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
Topics: Adrenergic beta-Antagonists; Binding Sites; Carbazoles; Cardiovascular Diseases; Carvedilol; Cell Line; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Long QT Syndrome; Membrane Potentials; Metoprolol; Mutation; Potassium Channel Blockers; Propanolamines; Propranolol; Protein Binding; Transfection | 2006 |